ArticleTranslational lung cancer research2025
A case series of nonintubated robotic-assisted bronchoscopy: a feasible alternative to intubated techniques.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in thoracic anesthesia: lung protection, airway management, and enhanced recovery-a narrative review.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robotic-assisted bronchoscopy (RAB) is widely used for pulmonary lesion management but is limited by its requirement for endotracheal intubation. In recent years, non-intubated anesthesia had emerged as an available alternative for thoracic procedure. Integrating RAB with a nonintubated approach may overcome current limitations, expand patient eligibility, and simplify procedural logistics. This study aims to evaluate the safety and feasibility of non-intubated RAB. Case Description: There were seven patients with 10 lesions underwent nonintubated RAB using the Monarch system. All procedures were successfully performed, with an average lesion size of 1.4 cm and a mean procedure time of 33.8 minutes. Pathology concordance was 100%, with 100% navigation accuracy. No intraoperative or postoperative complications occurred. Among them, five patients with positive diagnosis proceeded directly to thoracoscopic surgery under a single anesthetic regimen, avoiding the need for transitioning from single-lumen to double-lumen intubation. The mean interval between biopsy and resection was only 24.2 minutes, and recovery was rapid, with a mean postoperative recovery time of 26.7 minutes. Conclusions: Nonintubated RAB offers a safe, efficient, and flexible alternative to traditional intubated approach, particularly for patients with narrow airways or significant airway obstruction. By eliminating the need for inhalational anesthesia, this approach also aligns with sustainable practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.